Recent Articles from GlobeNewswire

DALLAS, April 03, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on April 1, 2026, the Compensation Committee of Taysha's Board of Directors granted four new employees, in the aggregate, restricted stock units (RSUs) representing 300,000 shares of the Company’s common stock and an option to purchase 92,400 shares of the Company's common stock in connection with their employment. The RSUs and stock option were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced that the Lotus brand will be represented at the New York International Auto Show, taking place April 3-12. The brand will showcase the latest Emira models, bringing Lotus’ performance legacy to one of North America’s most prominent automotive stages.

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- OpenArt, the leading AI video generation platform, has partnered with creator subscription platform, Fanvue, to launch the AI Personality of the Year Awards. The global programme is the first of its kind to recognise the achievements of AI Influencers across content excellence, cultural impact, and commercial success, with ElevenLabs joining in as a founding partner. 

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore immune balance and treat immune-mediated diseases and cancer, today announced that data from an investigator-initiated Phase II trial at Memorial Sloan Kettering Cancer Center, evaluating agent-797, MiNK’s allo-iNKT cell therapy, in combination with botensilimab (BOT) and balstilimab (BAL), will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17-22, 2026, in San Diego, CA.

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale, and trading of tokenized assets, today reported select preliminary operating data for the month and quarter ended March 31, 2026.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

Live Q&A to Address Company Strategy, Market Position, and the Future of Hydrogen

NEW YORK—Wix.com Ltd. (Nasdaq: WIX) (“Wix” or the “Company”) today announced the final results of its “modified Dutch Auction” tender offer, which expired at one (1) minute after 11:59 P.M., New York City time, on April 1, 2026. 

GANZI, China, April 03, 2026 (GLOBE NEWSWIRE) -- On April 2, the 2026 Conference on Cultural-Tourism Integration & the First Apricot Blossom Eco-Culture Week opened in Daofu County, Ganzi Tibetan Autonomous Prefecture, Sichuan, China. The event was hosted by the CPC Daofu County Committee and the Daofu County People's Government. With blooming apricot blossoms as its centerpiece, the event unveiled a series of tourism incentive policies and unique experiences, showcasing Daofu's innovative practices to integrate ecotourism with cultural heritage preservation.

FREMONT, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- Launching a Southeast Asian legal-tech startup in the U.S. is an exciting milestone, but it comes with a major hurdle: American buyers and investors are putting a magnifying glass on how you handle data. Founders who treat cross-border privacy as a core feature, rather than a last-minute chore, could be closing deals faster and winning over users much more easily. Research from the Future of Privacy Forum (FPF) underscores the growing complexity of navigating ASEAN privacy rules alongside fragmented U.S. state laws—a regulatory challenge that increasingly influences U.S. purchasing and investment decisions.

STMicroelectronics Announces Timing for First Quarter 2026 Earnings Release and Conference Call

3 April 2026, 8.00am CET

ARLINGTON, Va., April 03, 2026 (GLOBE NEWSWIRE) -- OwlTing Group (NASDAQ: OWLS) (“OwlTing” or the “Company”), the operating brand of OBOOK Holdings Inc., a global fintech company, today announced that it has entered into a Securities Purchase Agreement (the “SPA”) with Lind Global Asset Management XV LLC (the “Investor”), an investment fund managed by The Lind Partners, a New York-based institutional fund manager, for the issuance and sale of a convertible security (the “Convertible Security”) for US$10 million in gross proceeds. The arrangement will provide the Company with access to up to US$50 million in total funding, consisting of the initial US$10 million investment at closing of the Convertible Security (the “Closing”) and up to US$40 million in additional follow-on investments after effective resale registration, subject to similar terms and mutual consent of both parties. The Closing is expected to occur on or around April 6, 2026, subject to satisfaction of customary closing conditions. Benchmark, a StoneX Company, acted as exclusive placement agent.

Meridian, Idaho, April 02, 2026 (GLOBE NEWSWIRE) -- Get Lost Pest Control, a pest management provider serving Boise and the greater Treasure Valley, today announced a procedural update for new residential Service Plan customers. Under the new policy, the company will provide the first appointment at no cost while guaranteeing scheduling within two days. The announcement formalizes an operational shift intended to simplify onboarding for households seeking pest control services in the region.

Recognition Underscores the Firm’s Expansion as a Western New York–Based M&A Advisor Serving Clients Nationwide in Manufacturing, Industrial, and Healthcare

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE:KD), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --

Platform validated at a major Fortune 500 energy company, establishing an estimated 20× productivity ROI and 44% increase in active Copilot utilization within 90 days

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- If you have suffered a loss on your Gocery Outlet Holdings Corp. (“Grocery Outlet” or the “Company”) (NASDAQ:GO) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ:SMCI) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Kyndryl Holdings, Inc. (NYSE:KD) and Masonite International Corporation (NYSE:DOOR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Oddity (ODD) To Contact Him Directly To Discuss Their Options

LAKEWOOD, Colo., April 02, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In monday.com (MNDY) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Trip.com (TCOM) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In uniQure (QURE) To Contact Him Directly To Discuss Their Options

NAARDEN, the Netherlands and MIAMI, April 02, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 15,000 of NewAmsterdam’s ordinary shares to two non-executive new hires. The share options were granted as an inducement material to the employees acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).

BOCA RATON, FL, April 02, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (“DFDV” or the “Company”), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced it will host a live X Spaces event on Monday, April 6, 2026, at 1:00 PM ET.

TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced that it has successfully closed on an amendment to its credit facility with The Toronto-Dominion Bank and National Bank of Canada as co-lead arrangers and Royal Bank of Canada, JP Morgan Chase Bank, Export Development Canada and ATB Financial as lenders to extend the US$300 million senior secured revolving facility until October 2030.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In New Era Energy (NUAI) To Contact Him Directly To Discuss Their Options

Further to the press release of March 26, 2026 giving notice that the Golar LNG Limited 2026 Annual General Meeting will be held on May 19, 2026, a copy of the Notice of Annual General Meeting and associated information including the Company’s Annual Report on Form 20-F can be found on our website at https://www.golarlng.com and in the attachments below.

All amounts expressed in U.S. dollars

Month of Shows, Art, Ideas and Culture Returns to The Palm Beaches this May with Record Number of Deals and Special Experiences for All Ages

TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) will release its first quarter 2026 operating and financial results after the market closes on Wednesday April 29, 2026. The Company will host a conference call and webcast to discuss the results on Thursday April 30, 2026 at 9:00 a.m. Eastern Time. Details for the conference call and webcast are included below.

Introducing MGA’s Miniverse Real Music™: Big Hits Come to Life in Miniature with a Playable Mini Record Player and Collectible Mini Vinyls

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --

Move reflects continued execution of Weatherford’s free-cash-flow-focused strategy to streamline corporate structure, enhance capital management flexibility and deliver long-term shareholder value

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026

SAN FRANCISCO, April 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to four new employees to purchase an aggregate of 188,500 shares of the Company's common stock, effective as of April 1, 2026. These awards were approved by the Compensation Committee of Olema’s Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).

RED BANK, N.J., April 02, 2026 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp. (NASDAQ:OCFC), the holding company for OceanFirst Bank, today announced that it will issue its earnings release for the quarter ended March 31, 2026, on Thursday, April 23, 2026, after the market close. Management will then conduct a conference call at 11:00 a.m. Eastern Time, on Friday, April 24, 2026, to discuss highlights of the Company's quarterly operating performance.

Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of electronic health record data

HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- KBR‘s (NYSE: KBR) Mission Technology Solutions business is delivering critical services to support astronauts on NASA’s Artemis II mission as they embark on their journey around the moon – the first human mission beyond low-Earth orbit since Apollo 17 in 1972. From inside Mission Control, KBR teams are providing real-time monitoring and control of spacecraft systems and astronaut health, helping to ensure crew safety and the success of this landmark endeavor.

The company will showcase its self-custodial payments platform the day before Berkshire Hathaway’s annual shareholder meeting.

CALHOUN, Ga., April 02, 2026 (GLOBE NEWSWIRE) -- In conjunction with Mohawk Industries’ (NYSE: MHK) First Quarter 2026 earnings release on Thursday, April 30, 2026, you are invited to listen to the conference call that will be broadcast live on Friday, May 1, 2026, at 11:00 am ET.

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its first quarter 2026 earnings in a press release to be issued after the market closes on Tuesday, April 28, 2026.

CASTLE ROCK, Colo., April 02, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, announces unaudited production and operations updates for the first quarter of 2026.   Bitcoin Production and Operations Updates for Q1 2026

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) --

ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, 2026, at 8:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.

New portfolio structure reinforces ACM’s customer‑centric approach across core process technologies

Frances Allen and Felicia Thornton Bring Seasoned Retail Leadership and Operating Expertise to Board

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on April 1, 2026, the Company granted restricted stock units (RSUs) representing 7,260 shares of its common stock to one newly-hired non-executive employee. The grant was approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. (Nasdaq:ECPG), an international specialty finance company, announced today that it will release its financial results for the first quarter 2026 on Wednesday, May 6, 2026, after the market closes. The Company will also host a conference call and slide presentation the same day at 2:00 p.m. Pacific / 5:00 p.m. Eastern time with Ashish Masih, President and Chief Executive Officer, Tomas Hernanz, Executive Vice President and Chief Financial Officer, and Bruce Thomas, Vice President, Global Investor Relations, presenting and discussing the reported results.

CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that initial clinical results and preclinical data for zovegalisib (RLY-2608) in vascular anomalies will be presented at the International Society for the Study of Vascular Anomalies (ISSVA) World Congress 2026, taking place May 19-22, 2026, in Philadelphia. The company anticipates reporting clinical data on approximately 20 efficacy-evaluable patients.

NEW YORK and ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) -- Athyrium Capital Management, LP and Esperion Therapeutics, Inc. (Nasdaq: ESPR) today announced the entry into a $50 million royalty financing agreement under which certain funds managed by Athyrium Capital Management (the “Athyrium Funds”) will acquire 100% of Esperion’s royalty interest, held by Esperion pursuant to that certain License and Collaboration Agreement, dated as of April 17, 2020, as amended, by and among Esperion and Otsuka Pharmaceutical Co., Ltd (“Otsuka”), of Otsuka’s net sales of bempedoic acid products in Japan from and after January 1, 2026, together with related regulatory and commercial milestone payments, subject to a cap.

Jim O’Connor joins as Chief Business Officer and General Counsel

FOSTER CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of April 1, 2026 equity inducement awards to three new employees under the terms of the 2022 Employment Inducement Award Plan, as amended. The equity awards were approved by the Compensation Committee of the Company’s Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4) and were made as a material inducement to the employees’ acceptance of employment with Terns.

NEEDHAM, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that on March 31, 2026, the Compensation Committee of Candel’s Board of Directors (the Board) granted to five new employees, stock options to purchase an aggregate of 70,000 shares of the Company’s common stock, with a per share exercise price of $4.90.

NEWPORT BEACH, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the “Company” or “PMGC”) (NASDAQ: ELAB), a diversified holding company, today announced the launch of a new wholly owned subsidiary, NorthStrive Defense Tech LLC (“NorthStrive Defense Tech”). The Company plans for NorthStrive Defense Tech to operate in the defense technology sector, with an emphasis on drone technology, autonomous systems, and next generation unmanned defense solutions.

AUSTIN, Texas, April 02, 2026 (GLOBE NEWSWIRE) -- Ethos Technologies Inc. (NASDAQ: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it will release its financial results for the first quarter of 2026, which ended March 31, 2026, following the close of U.S. financial markets on Wednesday, May 6, 2026. The company’s earnings press release will be made available on the Ethos Investor Relations website at investors.ethos.com.

SANTA CLARA, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will release its financial results for the first quarter 2026 after the close of market on Tuesday, May 5, 2026. Astera Labs will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time.

HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- HMH Holding Inc. (“HMH”) (NASDAQ: HMH) today announced the closing of its initial public offering of 10,520,000 shares of its Class A common stock at $20.00 per share. The underwriters have a 30-day option to purchase up to an additional 1,578,000 shares of Class A common stock from HMH at the initial public offering price, less underwriting discounts and commissions. The shares of Class A common stock began trading on The Nasdaq Global Select Market on April 1, 2026 under the ticker symbol “HMH.” HMH received net proceeds from the offering of approximately $193.8 million, after deducting underwriting discounts and commissions and estimated offering expenses, and excluding any exercise of the underwriters’ option to purchase additional shares.

Southfield, Michigan, April 02, 2026 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) has been named one of the Fortune 100 Best Companies to Work For® in 2026 by Great Place To Work® and Fortune for the 12th time. This year, Credit Acceptance moved up 16 spots to #18, our highest ranking ever.

HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the closing of its previously announced best efforts public offering of an aggregate of 2,272,728 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,272,728 shares of common stock (the “Warrants”), at a combined public offering price of $1.32 per share (or per common stock equivalent in lieu thereof) and accompanying Warrant. The Warrants have an exercise price of $1.32 per share and are exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Warrants (the “Stockholder Approval”) and will expire on the five-year anniversary of the date of Stockholder Approval.

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Axonius, the asset intelligence platform for unified security operations and exposure management, today announced the full speaker and session lineup for Axonius Adapt 2026, its annual cybersecurity industry and customer conference taking place in person on April 15, 2026, at Cipriani Wall Street in New York City.

BOSTON, April 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on April 1, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 3,558 shares of its common stock to eighteen new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).

– Enbumyst, First and Only FDA-Approved Nasal Spray Loop Diuretic Now Integrated into Esperion’s Cardiovascular Franchise, Anticipated to Drive Portfolio Expansion, Commercial Leverage, and Continued Revenue Growth –

MONTREAL, April 02, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that it moved more than 2.96 million metric tonnes of grain from Western Canada, setting a new record for the month of March and achieved our highest ever first quarter results for grain movement. Weekly volumes exceeded 600,000 tonnes for two consecutive weeks, reaching a peak of over 650,000 tonnes, reflecting robust network performance and demand across both the West Coast and eastern corridors.

MDLifespan launches inside Cenegenics Miami and announces educational event with MDLifespan’s Dr. Pamela W. Smith on the latest break through in longevity and health optimization

MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million

Event highlights innovations and ecosystem integrations across IGEL's platform, spanning endpoint security, digital workspace delivery, and strategic partner expansion